Orchid Pharma

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue206.94228.03229.98252.18230.66
Expenses186.70197.48200.03223.07205.04
EBITDA31.8843.3541.8141.0237.55
EBIT24.0434.0933.4132.5728.93
Profit Before Tax20.2430.5529.9629.1025.63
Net Profit20.2430.5533.1929.1025.63
Financial Ratios
Operating Profit Margin16.04%19.65%19.26%16.78%16.86%
Net Profit Margin10.18%13.85%15.29%11.91%11.51%
Earning Per Share (Diluted)4.406.426.865.745.05
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ